541 related articles for article (PubMed ID: 17659851)
1. Stable sugar-based protein formulations by supercritical fluid drying.
Jovanović N; Bouchard A; Sutter M; Van Speybroeck M; Hofland GW; Witkamp GJ; Crommelin DJ; Jiskoot W
Int J Pharm; 2008 Jan; 346(1-2):102-8. PubMed ID: 17659851
[TBL] [Abstract][Full Text] [Related]
2. Distinct effects of sucrose and trehalose on protein stability during supercritical fluid drying and freeze-drying.
Jovanović N; Bouchard A; Hofland GW; Witkamp GJ; Crommelin DJ; Jiskoot W
Eur J Pharm Sci; 2006 Mar; 27(4):336-45. PubMed ID: 16338123
[TBL] [Abstract][Full Text] [Related]
3. Supercritical fluid drying of carbohydrates: selection of suitable excipients and process conditions.
Bouchard A; Jovanović N; Hofland GW; Jiskoot W; Mendes E; Crommelin DJ; Witkamp GJ
Eur J Pharm Biopharm; 2008 Mar; 68(3):781-94. PubMed ID: 17702554
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the physical properties of spray-dried stabilised lysozyme particles.
Liao YH; Brown MB; Quader A; Martin GP
J Pharm Pharmacol; 2003 Sep; 55(9):1213-21. PubMed ID: 14604464
[TBL] [Abstract][Full Text] [Related]
5. Supercritical fluid assisted atomization introduced by an enhanced mixer for micronization of lysozyme: Particle morphology, size and protein stability.
Du Z; Guan YX; Yao SJ; Zhu ZQ
Int J Pharm; 2011 Dec; 421(2):258-68. PubMed ID: 22001535
[TBL] [Abstract][Full Text] [Related]
6. Stabilization of IgG by supercritical fluid drying: optimization of formulation and process parameters.
Jovanović N; Bouchard A; Hofland GW; Witkamp GJ; Crommelin DJ; Jiskoot W
Eur J Pharm Biopharm; 2008 Feb; 68(2):183-90. PubMed ID: 17574824
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the stabilisation of freeze-dried lysozyme and the physical properties of the formulations.
Liao YH; Brown MB; Martin GP
Eur J Pharm Biopharm; 2004 Jul; 58(1):15-24. PubMed ID: 15207533
[TBL] [Abstract][Full Text] [Related]
8. Do co-spray dried excipients offer better lysozyme stabilisation than single excipients?
Hulse WL; Forbes RT; Bonner MC; Getrost M
Eur J Pharm Sci; 2008 Mar; 33(3):294-305. PubMed ID: 18262776
[TBL] [Abstract][Full Text] [Related]
9. A solid-state NMR study of molecular mobility and phase separation in co-spray-dried protein-sugar particles.
Suihko EJ; Forbes RT; Apperley DC
Eur J Pharm Sci; 2005 May; 25(1):105-12. PubMed ID: 15854806
[TBL] [Abstract][Full Text] [Related]
10. Effect of the spraying conditions and nozzle design on the shape and size distribution of particles obtained with supercritical fluid drying.
Bouchard A; Jovanović N; de Boer AH; Martín A; Jiskoot W; Crommelin DJ; Hofland GW; Witkamp GJ
Eur J Pharm Biopharm; 2008 Sep; 70(1):389-401. PubMed ID: 18534833
[TBL] [Abstract][Full Text] [Related]
11. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations.
Schüle S; Friess W; Bechtold-Peters K; Garidel P
Eur J Pharm Biopharm; 2007 Jan; 65(1):1-9. PubMed ID: 17034996
[TBL] [Abstract][Full Text] [Related]
12. Trehalose and hyaluronic acid coordinately stabilized freeze-dried pancreatic kininogenase.
Zhang Y; Ji B; Ling P; Zhang T
Eur J Pharm Biopharm; 2007 Jan; 65(1):18-25. PubMed ID: 16950608
[TBL] [Abstract][Full Text] [Related]
13. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage.
Passot S; Fonseca F; Alarcon-Lorca M; Rolland D; Marin M
Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475
[TBL] [Abstract][Full Text] [Related]
14. Particle size dependence of polymorphism in spray-dried mannitol.
Lee YY; Wu JX; Yang M; Young PM; van den Berg F; Rantanen J
Eur J Pharm Sci; 2011 Sep; 44(1-2):41-8. PubMed ID: 21699976
[TBL] [Abstract][Full Text] [Related]
15. The influence of lysozyme on mannitol polymorphism in freeze-dried and spray-dried formulations depends on the selection of the drying process.
Grohganz H; Lee YY; Rantanen J; Yang M
Int J Pharm; 2013 Apr; 447(1-2):224-30. PubMed ID: 23500620
[TBL] [Abstract][Full Text] [Related]
16. Scalable organic solvent free supercritical fluid spray drying process for producing dry protein formulations.
Nuchuchua O; Every HA; Hofland GW; Jiskoot W
Eur J Pharm Biopharm; 2014 Nov; 88(3):919-30. PubMed ID: 25262979
[TBL] [Abstract][Full Text] [Related]
17. The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with L-leucine.
Najafabadi AR; Gilani K; Barghi M; Rafiee-Tehrani M
Int J Pharm; 2004 Nov; 285(1-2):97-108. PubMed ID: 15488683
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the sucrose/glycine/water system by differential scanning calorimetry and freeze-drying microscopy.
Kasraian K; Spitznagel TM; Juneau JA; Yim K
Pharm Dev Technol; 1998 May; 3(2):233-9. PubMed ID: 9653761
[TBL] [Abstract][Full Text] [Related]
19. Particle engineering of materials for oral inhalation by dry powder inhalers. I-Particles of sugar excipients (trehalose and raffinose) for protein delivery.
Ogáin ON; Li J; Tajber L; Corrigan OI; Healy AM
Int J Pharm; 2011 Feb; 405(1-2):23-35. PubMed ID: 21129458
[TBL] [Abstract][Full Text] [Related]
20. Influence of protein on mannitol polymorphic form produced during co-spray drying.
Hulse WL; Forbes RT; Bonner MC; Getrost M
Int J Pharm; 2009 Dec; 382(1-2):67-72. PubMed ID: 19682563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
